Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer
Open Access
- 27 January 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (1), e8819
- https://doi.org/10.1371/journal.pone.0008819
Abstract
A potential strategy for diagnosing lung cancer, the leading cause of cancer-related death, is to identify metabolic signatures (biomarkers) of the disease. Although data supports the hypothesis that volatile compounds can be detected in the breath of lung cancer patients by the sense of smell or through bioanalytical techniques, analysis of breath samples is cumbersome and technically challenging, thus limiting its applicability. The hypothesis explored here is that variations in small molecular weight volatile organic compounds (“odorants”) in urine could be used as biomarkers for lung cancer. To demonstrate the presence and chemical structures of volatile biomarkers, we studied mouse olfactory-guided behavior and metabolomics of volatile constituents of urine. Sensor mice could be trained to discriminate between odors of mice with and without experimental tumors demonstrating that volatile odorants are sufficient to identify tumor-bearing mice. Consistent with this result, chemical analyses of urinary volatiles demonstrated that the amounts of several compounds were dramatically different between tumor and control mice. Using principal component analysis and supervised machine-learning, we accurately discriminated between tumor and control groups, a result that was cross validated with novel test groups. Although there were shared differences between experimental and control animals in the two tumor models, we also found chemical differences between these models, demonstrating tumor-based specificity. The success of these studies provides a novel proof-of-principle demonstration of lung tumor diagnosis through urinary volatile odorants. This work should provide an impetus for similar searches for volatile diagnostic biomarkers in the urine of human lung cancer patients.This publication has 38 references indexed in Scilit:
- Genetically-Based Olfactory Signatures Persist Despite Dietary VariationPLOS ONE, 2008
- An Experimental Biomimetic Platform for Artificial OlfactionPLOS ONE, 2008
- Imaging in the era of molecular oncologyNature, 2008
- Detection of Near-Atmospheric Concentrations of CO 2 by an Olfactory Subsystem in the MouseScience, 2007
- Biomarkers for lung cancer: clinical usesCurrent Opinion in Pulmonary Medicine, 2007
- Computed Tomography Screening and Lung Cancer OutcomesJAMA, 2007
- Odortypes and MHC peptides: complementary chemosignals of MHC haplotype?Trends in Neurosciences, 2006
- Intrapulmonary IFN-β Gene Therapy Using an Adenoviral Vector Is Highly Effective in a Murine Orthotopic Model of Bronchogenic Adenocarcinoma of the LungCancer Research, 2005
- Identification of Major Histocompatibility Complex-Regulated Body Odorants by Statistical Analysis of a Comparative Gas Chromatography/Mass Spectrometry ExperimentAnalytical Chemistry, 2005
- Olfactory detection of human bladder cancer by dogs: proof of principle studyBMJ, 2004